Short-term efficacy of right-to-left shunt closure in patients with vestibular migraine
- PMID: 39734627
- PMCID: PMC11672335
- DOI: 10.3389/fneur.2024.1500918
Short-term efficacy of right-to-left shunt closure in patients with vestibular migraine
Abstract
Objective: This study aims to evaluate the short-term efficacy of right-to-left shunt closure in vestibular migraine patients, and compare the efficacy between patent foramen ovale (PFO) closure and pulmonary arteriovenous malformation (PAVM) embolization. Additionally, the study identifies factors related to surgical outcomes.
Methods: Forty-one patients with vestibular migraine and medium to large right-to-left shunts underwent surgery: PFO closure, PAVM embolization, or both. Baseline data and postoperative outcomes at one month, including migraine and dizziness frequency, duration, VAS, HIT-6, migraine scores, and DHI scores, were analyzed. The correlation between efficacy and baseline data was analyzed.
Results: At one month postoperatively, the frequency and duration of dizziness and migraine attacks significantly decreased, and the VAS, HIT-6, migraine scores, and DHI scores all significantly dropped (p < 0.001). There was no significant difference in the improvement rates of VAS, HIT-6, migraine scores, and DHI scores between the PFO group and the PAVM group (p > 0.05). Red blood cell parameters positively correlated with the improvement rates of VAS, HIT-6, migraine scores, and DHI. This approach was more effective in male patients than in female patients (p < 0.05).
Conclusion: Right-to-left shunt closure has a significant short-term effect on patients with vestibular migraine, regardless of the shunt location. Red blood cell parameters may serve as predictive indicators for the surgical efficacy in these patients.
Keywords: efficacy; patent foramen ovale; pulmonary arteriovenous malformation; right-to-left shunt closure; vestibular migraine.
Copyright © 2024 Lang, Zhang, Xie, Wang, Wang, Wang, Zhu and Gu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.JACC Cardiovasc Interv. 2020 Feb 10;13(3):293-302. doi: 10.1016/j.jcin.2019.09.042. JACC Cardiovasc Interv. 2020. PMID: 32029246
-
Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up.Front Neurol. 2019 Nov 19;10:1224. doi: 10.3389/fneur.2019.01224. eCollection 2019. Front Neurol. 2019. PMID: 31803135 Free PMC article.
-
Efficacy and safety of transesophageal ultrasound-guided patent foramen ovale closure for migraine in adolescents.Front Pediatr. 2023 Nov 15;11:1296825. doi: 10.3389/fped.2023.1296825. eCollection 2023. Front Pediatr. 2023. PMID: 38046679 Free PMC article.
-
Association of migraine with patent foramen ovale closure: A systematic review and meta-analysis.Int J Cardiol Heart Vasc. 2022 Mar 18;39:100992. doi: 10.1016/j.ijcha.2022.100992. eCollection 2022 Apr. Int J Cardiol Heart Vasc. 2022. PMID: 35330668 Free PMC article. Review.
-
Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.Rev Recent Clin Trials. 2017;12(2):129-138. doi: 10.2174/1574887112666170328124939. Rev Recent Clin Trials. 2017. PMID: 28356032 Review.
References
LinkOut - more resources
Full Text Sources